| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10738145 | Free Radical Biology and Medicine | 2012 | 8 Pages |
Abstract
⺠Currently there is no effective therapy for nonalcoholic fatty liver disease, except for lifestyle modification. ⺠Realsil treatment for 12 months improves liver enzymes, insulin resistance, and liver histology. ⺠HCV patients in the Realsil group showed improvements in fibrogenesis markers.
Keywords
TGFNAFLDTNFγGTSF-36NASALTMMPγ-glutamyltranspeptidaseASTAspartate aminotransferaseAlanine aminotransferaseAntioxidantHomeostatic model assessmentnonalcoholic steatohepatitisinterleukinNonalcoholic fatty liver diseasetransforming growth factorper protocolFree radicalsTIMPSilybinbody mass indexBMIadverse eventtumor necrosis factorShort Form 36matrix metalloproteinaseTissue inhibitor of metalloproteinaseNAFLD activity scoreNash HOMAHepatitis C virusHCVPlaceboNonalcoholic fatty liver
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Carmela Loguercio, Pietro Andreone, Ciprian Brisc, Michaela Cristina Brisc, Elisabetta Bugianesi, Maria Chiaramonte, Carmela Cursaro, Mirela Danila, Ilario de Sio, Annarosa Floreani, Maria Antonietta Freni, Antonio Grieco, Marzia Groppo, Roberta Lazzari,